Exemestane + Celecoxib vs Exemestane + Placebo in Metastatic Breast Cancer

Clinical trial NCT00525096 · COMPLETED

Trial details

NCT number: NCT00525096
Sponsor: ARCAGY/ GINECO GROUP
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic Breast Cancer

Start date: 2003-07-01
Primary completion: 2004-12-01
Enrollment: 157

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.